AI-device developer earns 2nd FDA approval

Artificial intelligence device-maker NinePoint Medical received FDA approval for its NvisionVLE Imaging System.

Advertisement

Surgeons can use the imaging system in the pancreas and bile duct to capture real-time images of the tissue surface and subsurface. The technology allows gastroenterologists to evaluate tissue in regions that traditional medical imaging technologies can’t capture.

NinePoint earned FDA approval for the first AI-based imaging technology in gastroenterology in November 2018.

More articles on surgery centers: 
$12M ASC completed in North Dakota
Joint-venture ASC opens location near UK HealthCare — 5 insights
Minnesota hospital planning ASC

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.